Davis Polk advised the underwriters in the offering.
Priveterra Acquisition Corp. executed its $276 million initial public offering of 27,600,000 units, which includes 3,600,000 units from the full exercise of the underwriters’ over-allotment option to purchase additional units. Each unit consists of one common share and one redeemable warrant to purchase one-third common share of Priveterra Acquisition Corp. The units were listed on the Nasdaq Capital Market under the symbol “PMGMU.”
Wells Fargo Securities, LLC, Guggenheim Securities, LLC, and Odeon Capital Group, LLC acted as underwriters for the offeirng.
Priveterra Acquisition Corp. is a newly organized, special purpose acquisition company (SPAC) formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses or entities. As such, Priveterra Acquisition Corp. intends to pursue prospective targets on the medical technology sector.
The Davis Polk corporate team included partner Derek Dostal (Picture) and associate Ernesto Talamas Velazquez. The tax team included counsel Kiara L. Rankin and associate Rebecca A. Rosen. Counsel Marcie A. Goldstein provided FINRA advice.
Involved fees earner: Derek Dostal – Davis Polk & Wardwell; Marcie Goldstein – Davis Polk & Wardwell; Kiara Rankin – Davis Polk & Wardwell; Rebecca Rosen – Davis Polk & Wardwell; Ernesto Talamás Velázquez – Davis Polk & Wardwell;
Law Firms: Davis Polk & Wardwell;